Kestra Advisory Services LLC Has $4.60 Million Stake in GE HealthCare Technologies Inc. $GEHC

Kestra Advisory Services LLC grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 64,641 shares of the company’s stock after purchasing an additional 12,561 shares during the period. Kestra Advisory Services LLC’s holdings in GE HealthCare Technologies were worth $4,601,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Banque Cantonale Vaudoise lifted its position in shares of GE HealthCare Technologies by 16,539.1% in the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock worth $1,849,000 after purchasing an additional 25,801 shares in the last quarter. Allstate Corp grew its position in GE HealthCare Technologies by 100.3% in the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after purchasing an additional 16,365 shares in the last quarter. Salem Investment Counselors Inc. increased its stake in GE HealthCare Technologies by 9.2% in the 4th quarter. Salem Investment Counselors Inc. now owns 176,452 shares of the company’s stock valued at $14,473,000 after buying an additional 14,867 shares during the last quarter. Nordea Investment Management AB lifted its position in GE HealthCare Technologies by 564.4% during the 4th quarter. Nordea Investment Management AB now owns 284,344 shares of the company’s stock worth $23,515,000 after buying an additional 241,548 shares in the last quarter. Finally, Northside Capital Management LLC lifted its position in GE HealthCare Technologies by 16.4% during the 4th quarter. Northside Capital Management LLC now owns 163,614 shares of the company’s stock worth $13,420,000 after buying an additional 23,107 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Kevin Lobo purchased 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO James Saccaro purchased 3,310 shares of the stock in a transaction on Friday, May 1st. The stock was bought at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the acquisition, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on GEHC. Piper Sandler decreased their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a report on Wednesday, April 29th. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Evercore set a $80.00 price target on GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $85.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $79.38.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $65.70 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The firm has a market capitalization of $29.89 billion, a price-to-earnings ratio of 15.72, a P/E/G ratio of 1.72 and a beta of 0.72. The stock’s 50 day moving average price is $63.65 and its two-hundred day moving average price is $72.03. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same period in the previous year, the firm posted $1.01 earnings per share. The firm’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is currently 3.35%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.